SearcharxivSearch

arXiv subjects

Qingfei Luo

Publications and source records attributed to Qingfei Luo.

3 recordsLinked to original sources

Three-dimensional echo-shifted EPI with simultaneous blip-up and blip-down acquisitions for correcting geometric distortion

Purpose: Echo-planar imaging (EPI) with blip-up/down acquisition (BUDA) can provide high-quality images with minimal distortions by using two readout trains with opposing phase-encoding gradients. Because of the need for two separate acquisitions, BUDA doubles the scan time and degrades the temporal resolution when compared to single-shot EPI, presenting a major challenge for many applications, particularly functional MRI (fMRI). This study aims at overcoming this challenge by developing an echo-shifted EPI BUDA (esEPI-BUDA) technique to acquire both blip-up and blip-down datasets in a single shot. Methods: A three-dimensional (3D) esEPI-BUDA pulse sequence was designed by using an echo-shifting strategy to produce two EPI readout trains. These readout trains produced a pair of k-space datasets whose k-space trajectories were interleaved with opposite phase-encoding gradient directions. The two k-space datasets were separately reconstructed using a 3D SENSE algorithm, from which time-resolved B0-field maps were derived using TOPUP in FSL and then input into a forward model of joint parallel imaging reconstruction to correct for geometric distortion. In addition, Hankel structured low-rank constraint was incorporated into the reconstruction framework to improve image quality by mitigating the phase errors between the two interleaved k-space datasets. Results: The 3D esEPI-BUDA technique was demonstrated in a phantom and an fMRI study on healthy human subjects. Geometric distortions were effectively corrected in both phantom and human brain images. In the fMRI study, the visual activation volumes and their BOLD responses were comparable to those from conventional 3D echo-planar images. Conclusion: The improved imaging efficiency and dynamic distortion correction capability afforded by 3D esEPI-BUDA are expected to benefit many EPI applications.

physics.med-ph

Automated Pipeline for EEG Artifact Reduction (APPEAR) Recorded during fMRI

Objective. EEG data collected during fMRI acquisition are contaminated with MRI gradients and ballistocardiogram (BCG) artifacts, in addition to artifacts of physiological origin. There have been several attempts for reducing these artifacts with manual and time-consuming pre-processing, which may result in biasing EEG data due to variations in selecting steps order, parameters, and classification of artifactual independent components. Thus, there is a strong urge to develop a fully automatic and comprehensive pipeline for reducing all major EEG artifacts. In this work, we introduced an open-access toolbox with a fully automatic pipeline for reducing artifacts from EEG data collected simultaneously with fMRI (refer to APPEAR). Approach. The pipeline integrates average template subtraction and independent component analysis (ICA) to suppress both MRI-related and physiological artifacts. To validate our results, we tested APPEAR on EEG data recorded from healthy control subjects during resting-state (n=48) and task-based (i.e., event-related-potentials [ERP]; n=8) paradigms. The chosen gold standard is an expert manual review of the EEG database. Main results. We compared manually and automated corrected EEG data during resting-state using frequency analysis and continuous wavelet transformation and found no significant differences between the two corrections. A comparison between ERP data recorded during a so-called stop-signal task (e.g., amplitude measures and signal-to-noise ratio) also showed no differences between the manually and fully automatic fMRI-EEG-corrected data. Significance: APPEAR offers the first comprehensive open-source toolbox that can speed up advancement of EEG analysis and enhance replication by avoiding experimenters' preferences while allowing for processing large EEG-fMRI cohorts composed of hundreds of subjects with manageable researcher time and effort.

eess.SP

Integration of Simultaneous Resting-State Electroencephalography, Functional Magnetic Resonance Imaging, and Eye-Tracker Methods to Determine and Verify Electroencephalography Vigilance Measure

Background/Introduction: Concurrent electroencephalography and resting-state functional magnetic resonance imaging (rsfMRI) have been widely used for studying the (presumably) awake and alert human brain with high temporal/spatial resolution. Although rsfMRI scans are typically collected while individuals are instructed to focus their eyes on a fixated cross, objective and verified experimental measures to quantify degree of vigilance are not readily available. Electroencephalography (EEG) is the modality extensively used for estimating vigilance, especially during eyes-closed resting state. However, pupil size measured using an eye-tracker device could provide an indirect index of vigilance. Methods: Three 12-min resting scans (eyes open, fixating on the cross) were collected from 10 healthy control participants. We simultaneously collected EEG, fMRI, physiological, and eye-tracker data and investigated the correlation between EEG features, pupil size, and heart rate. Furthermore, we used pupil size and EEG features as regressors to find their correlations with blood-oxygen-level-dependent fMRI measures. Results: EEG frontal and occipital beta power (FOBP) correlates with pupil size changes, an indirect index for locus coeruleus activity implicated in vigilance regulation (r = 0.306, p < 0.001). Moreover, FOBP also correlated with heart rate (r = 0.255, p < 0.001), as well as several brain regions in the anticorrelated network, including the bilateral insula and inferior parietal lobule. Discussion: In this study, we investigated whether simultaneous EEG-fMRI combined with eye-tracker measurements can be used to determine EEG signal feature associated with vigilance measures during eyes-open rsfMRI. Our results support the conclusion that FOBP is an objective measure of vigilance in healthy human subjects.

eess.SP